LATIN AMERICA STEM CELL MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

LATIN AMERICA STEM CELL MARKET 2021-2028

Market by Therapeutic Application, Technology, Treatment Type, Product, Application, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s report intimates that the Latin American stem cell market is probable to showcase growth at a CAGR of 6.18% during the assessed period 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries analyzed in this market include:

•        Brazil

•        Mexico

•        Rest of Latin America

In Brazil, among the urology diseases, prostate cancer, overactive bladder, renal diseases, and urinary tract infections are significant conditions that are highly prevalent. Due to the low availability and elevated cost of procedures, hospitals usually have long waiting lists for kidney transplants. Furthermore, several publications relating to regenerative medicines and stem cell research in treating numerous diseases, including brain cancer and diabetes, have gained significant traction. Moreover, several research centers in the country are supporting stem cell biology. These factors indicate a steady rise of the stem cell market during the estimated years across Brazil.

On the other hand, the government is known to invest mainly in improving Mexico’s healthcare infrastructure. Although, the country has variant healthcare systems such as public, private, and social security schemes, which further leads to multiple inconsistencies in health coverage and related policies. Nevertheless, Mexico is considered one of the popular medical tourism destinations, with tourists seeking affordable and effective treatments. This is one of the major factors expected to influence the demand for stem cell therapies.

Further, the Global Institute of Stem Cell Therapy and Research is among the leading stem cell research companies worldwide, offering stem cell therapy for anti-aging diseases, several sclerosis, and other injuries. Hence, such developments in the healthcare facilities are likely to propel the stem cell market on a positive growth path across Mexico.

StemCell Technologies is a biotechnology company cultivating specialty cell culture, cell isolation systems, and accessory products for life science research activities. It develops its products to assist the overall experimental workflows, including expansion, maintenance, differentiation, and storage, among others. The company has extended its product portfolio to include a detailed suite of immune cell isolation devices, and products supporting research by utilizing pluripotent and mesenchymal stem cells. It serves its broad client base in several regions, such as North America and Latin America. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    LATIN AMERICA STEM CELL MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES MODEL

2.1.1.   THREAT OF NEW ENTRANTS

2.1.2.   THREAT OF SUBSTITUTE PRODUCTS

2.1.3.   BARGAINING POWER OF BUYERS

2.1.4.   BARGAINING POWER OF SUPPLIERS

2.1.5.   COMPETITIVE RIVALRY

2.2. IMPACT OF COVID-19 ON STEM CELL MARKET

2.3. KEY IMPACT ANALYSIS

2.4. INDUSTRY COMPONENTS

2.5. LEGAL, POLICY, & REGULATORY FRAMEWORK

2.6. MARKET ATTRACTIVENESS INDEX

2.7. VENDOR SCORECARD

2.8. KEY INSIGHTS

2.9. MARKET DRIVERS

2.9.1.   GROWING AWARENESS ABOUT UMBILICAL CORD STEM CELLS

2.9.2.   SURGE IN STEM CELL RESEARCH AND DEVELOPMENT

2.9.3.   RISING DEMAND FOR REGENERATIVE MEDICINE

2.10. MARKET RESTRAINTS

2.10.1.   ETHICAL CONCERNS ASSOCIATED WITH STEM CELLS

2.10.2.   HIGH COST OF STEM CELL PROCEDURES

2.10.3.   STRINGENT REGULATIONS IN TERMS OF STEM CELL THERAPY

2.11. MARKET OPPORTUNITIES

2.11.1.   ADVANCEMENT IN TECHNOLOGY

2.11.2.   RISK OF ADVERSE IMMUNE REACTIONS AND COMPLICATIONS

3.    LATIN AMERICA STEM CELL MARKET OUTLOOK - BY THERAPEUTIC APPLICATION

3.1. NEUROLOGICAL DISORDERS

3.2. ONCOLOGY DISORDERS

3.3. DIABETES

3.4. INJURIES AND WOUNDS

3.5. ORTHOPEDIC TREATMENTS

3.6. CARDIOVASCULAR DISORDERS

3.7. OTHER THERAPEUTIC APPLICATIONS

4.    LATIN AMERICA STEM CELL MARKET OUTLOOK - BY TECHNOLOGY

4.1. CRYOPRESERVATION

4.2. ACQUISITION

4.2.1.   STEM CELL APHERESIS

4.2.2.   STEM CELL BONE MARROW MARKET

4.2.3.   STEM CELL UMBILICAL CORD

4.3. EXPANSION AND SUB-CULTURE

4.4. PRODUCTION

4.4.1.   STEM CELL CULTURE

4.4.2.   THERAPEUTIC CLONING

4.4.3.   IVF

5.    LATIN AMERICA STEM CELL MARKET OUTLOOK - BY TREATMENT TYPE

5.1. ALLOGENEIC STEM CELL THERAPY

5.2. AUTOLOGIC STEM CELL THERAPY

5.3. SYNGENEIC STEM CELL THERAPY

6.    LATIN AMERICA STEM CELL MARKET OUTLOOK - BY PRODUCT

6.1. ADULT STEM CELL

6.1.1.   HEMATOPOIETIC STEM CELL

6.1.2.   NEURAL STEM CELL

6.1.3.   UMBILICAL CORD STEM CELL

6.1.4.   MESENCHYMAL STEM CELL

6.1.5.   DENTAL STEM CELL

6.2. HUMAN EMBRYONIC STEM CELL

6.3. PLURIPOTENT

6.4. MOUSE/RAT NEURAL

7.    LATIN AMERICA STEM CELL MARKET OUTLOOK - BY APPLICATION

7.1. REGENERATIVE MEDICINE

7.2. DRUG DISCOVERY AND DEVELOPMENT

8.    GEOGRAPHICAL ANALYSIS - LATIN AMERICA

8.1. COUNTRY ANALYSIS

8.1.1.   MEXICO

8.1.2.   BRAZIL

8.1.3.   REST OF LATIN AMERICA

9.    COMPANY PROFILES

9.1. CORNING INC

9.2. STEMCELL TECHNOLOGIES

9.3. STRYKER CORPORATION

9.4. BECTON DICKINSON AND COMPANY (BD)

9.5. CYTORI THERAPEUTICS

9.6. QIAGEN NV

9.7. GE HEALTHCARE

9.8. TAKARA HOLDINGS

9.9. SMITH & NEPHEW PLC

9.10. INTERNATIONAL STEM CELL CORP

9.11. MILTENYI BIOTEC

9.12. MERCK KGAA (SIGMA ALDRICH)

9.13. THERMO FISHER SCIENTIFIC INC

9.14. ALLCELLS LLC

9.15. PLURISTEM THERAPEUTICS INC

10. RESEARCH METHODOLOGY & SCOPE

10.1. RESEARCH SCOPE & DELIVERABLES

10.1.1.   OBJECTIVES OF STUDY

10.1.2.   SCOPE OF STUDY

10.2. SOURCES OF DATA

10.2.1.   PRIMARY DATA SOURCES

10.2.2.   SECONDARY DATA SOURCES

10.3. RESEARCH METHODOLOGY

10.3.1.   EVALUATION OF PROPOSED MARKET

10.3.2.   IDENTIFICATION OF DATA SOURCES

10.3.3.   ASSESSMENT OF MARKET DETERMINANTS

10.3.4.   DATA COLLECTION

10.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        LATIN AMERICA STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2        VENDOR SCORECARD

TABLE 3        LATIN AMERICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 4        LATIN AMERICA STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 5        LATIN AMERICA ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6        LATIN AMERICA PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 7        LATIN AMERICA STEM CELL MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)

TABLE 8        LATIN AMERICA STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 9        LATIN AMERICA ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 10      LATIN AMERICA STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 11      LATIN AMERICA STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1      LATIN AMERICA STEM CELL MARKET, 2021-2028, (IN $ MILLION)

FIGURE 2      LATIN AMERICA STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 3      LATIN AMERICA STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 4      LATIN AMERICA STEM CELL MARKET, BY DIABETES, 2021-2028 (IN $ MILLION)

FIGURE 5      LATIN AMERICA STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)

FIGURE 6      LATIN AMERICA STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)

FIGURE 7      LATIN AMERICA STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 8      LATIN AMERICA STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 9      LATIN AMERICA STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION)

FIGURE 10   LATIN AMERICA STEM CELL MARKET, BY ACQUISITION, 2021-2028 (IN $ MILLION)

FIGURE 11   LATIN AMERICA STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 12   LATIN AMERICA STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION)

FIGURE 13   LATIN AMERICA STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION)

FIGURE 14   LATIN AMERICA STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION)

FIGURE 15   LATIN AMERICA STEM CELL MARKET, BY PRODUCTION, 2021-2028 (IN $ MILLION)

FIGURE 16   LATIN AMERICA STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2028 (IN $ MILLION)

FIGURE 17   LATIN AMERICA STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)

FIGURE 18   LATIN AMERICA STEM CELL MARKET, BY IVF, 2021-2028 (IN $ MILLION)

FIGURE 19   LATIN AMERICA STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 20   LATIN AMERICA STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 21   LATIN AMERICA STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 22   LATIN AMERICA STEM CELL MARKET, BY ADULT STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 23   LATIN AMERICA STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 24   LATIN AMERICA STEM CELL MARKET, BY NEURAL STEM, 2021-2028 (IN $ MILLION)

FIGURE 25   LATIN AMERICA STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 26   LATIN AMERICA STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 27   LATIN AMERICA STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 28   LATIN AMERICA STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 29   LATIN AMERICA STEM CELL MARKET, BY PLURIPOTENT, 2021-2028 (IN $ MILLION)

FIGURE 30   LATIN AMERICA STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION)

FIGURE 31   LATIN AMERICA STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)

FIGURE 32   LATIN AMERICA STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)

FIGURE 33   MEXICO STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 34   BRAZIL STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 35   REST OF LATIN AMERICA STEM CELL MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;